Skip to search formSkip to main contentSkip to account menu

Lamictal

Known as: Lamiktal, lamictal [brand name] 
brand name of lamotrigine
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Introduction: Over the past decade the use of lamotrigine in bipolar disorder has increased. However, the evidence base suggests… 
2010
2010
BackgroundThis report describes two cases with unexplained positive results for phencyclidine (PCP).AimsThis case will correlate… 
Highly Cited
2007
Highly Cited
2007
Summary:  Purpose: Compulsory generic substitution of antiepileptic drugs (AEDs) may lead to adverse effects in epilepsy patients… 
Review
2004
Review
2004
AbstractLamotrigine (Lamictal®), a phenyltriazine derivative, is a well established anticonvulsant agent that has shown efficacy… 
Highly Cited
1999
Highly Cited
1999
Summary: Purpose: To investigate whether lamotrigine (LTG) monotherapy is effective and safe for newly diagnosed typical absence… 
Highly Cited
1995
Highly Cited
1995
Actions of the new antiepileptic drug lamotrigine (LTG, Lamictal) were characterised using recombinant rat brain type IIA Na… 
1991
1991
An immunofluorometric assay (IFA) has been developed for the potential antiepileptic agent, lamotrigine (Lamictal). The assay… 
1991
1991
The kinetics of lamotrigine (LTG) disposition in plasma and saliva was evaluated in patients undergoing long-term antiepileptic…